Abstract

Influenza A virus (IAV) is a major global public health burden due to its routine evasion of immunization strategies. Natural killer (NK) cells are innate cytotoxic cells with important antiviral activity in the human body, yet the function of these cells in the control of IAV infection is unclear. The aim of this study was to determine the role of lung NK cell cytotoxic responses to IAV. Human lung explants were infected ex vivo with IAV, and lung NK cell activation was analyzed by flow cytometry. Cytotoxic responses of NK cell subsets against IAV-infected macrophages were measured by flow cytometry and ELISA. Despite reports of hypofunctionality in the pulmonary environment, human lung-associated NK cells responded rapidly to ex vivo IAV infection, with upregulation of surface CD107a 24 h post-infection. The lung NK cell phenotype is similar in maturity and differentiation to NK cells of the peripheral blood but a unique CD56brightCD49a+CD103+CD69+ NK cell population was identified in the lung, indicating NK cell residency within this organ. In response to ex vivo IAV infection a greater proportion of resident CD56brightCD49a+ NK cells expressed surface CD107a compared with CD56brightCD49a− NK cells, suggesting a hyperfunctional NK cell population may be present within human lung tissue and could be the result of innate immunological training. Furthermore, NK cells provided significant antiviral, cytotoxic activity following contact with influenza-infected cells, including the production and release of IFN-γ and granzyme-B resulting in macrophage cell death. These results suggest that a resident, trained NK cell population are present in the human lung and may provide early and important control of viral infection. A greater understanding of this resident mucosal population may provide further insight into the role of these cells in controlling viral infection and generating appropriate adaptive immunity to IAV.

Highlights

  • Influenza A virus (IAV) is a single-stranded ribonucleic acid virus of the Orthomyxoviridae family causing acute infection of the upper and lower respiratory tract [1]

  • natural killer (NK) cells were defined as CD45+CD3−CD56+ cells by flow cytometry and made up a median of 18.55 ± 14.98% of CD45+ lymphocytes isolated from the human lung parenchyma (N = 17, Figure 1)

  • CD56brightCD16−, CD56dimCD16+, and CD56dimCD16− NK cells were all identified in lung and blood with and those undergoing cancer resection [peripheral blood from cancer resection donor (CR-PB)]. (A) Representative gating strategy to define NK cells and NK cell subpopulations isolated from human lung parenchyma. (B) Quantification of lung CD45+ lymphocytes, N = 23. (C–E) Proportions of CD56bright, CD56dimCD16+, and CD56dimCD16− NK cells in healthy peripheral blood (H-PB) (N = 14), lung tissue (N = 23), and matched blood (CR-PB, N = 23)

Read more

Summary

Introduction

Influenza A virus (IAV) is a single-stranded ribonucleic acid virus of the Orthomyxoviridae family causing acute infection of the upper and lower respiratory tract [1]. Vaccination is currently the best method of controlling viral transmission; annual influenza vaccines are limited in efficacy due to rapid viral evolution, time required for production and ineffectiveness in high-risk groups [3, 4]. NK cells aid viral clearance through secretion of pro-inflammatory cytokines such as IFN-γ as well as cytotoxic granules and engagement of death receptors, which stimulate target cell apoptosis [8]. CD56bright NK cells are thought to be predominantly cytokine producing while CD56dim NK cells represent the canonical cytotoxic NK cell; these functional outputs appear dependent on the type of in vitro stimulation and the role of these NK cell subtypes within the human body remain largely unexplored [10,11,12,13,14]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.